Associated tags: Friendly, University, OXFORD, Vaccine, Oxitec, Pharmaceutical industry, Fever Dream, US, Biting, Incidence, Human, Anopheles, Malaria, Progress, City, Environment, Horn, Aedes aegypti, Bill, Animal
Retrieved on:
Thursday, August 18, 2022
City,
Country,
University,
CEO,
Mental health,
Technology,
Metropolitan,
OXFORD,
Life,
Chikungunya,
Oxitec,
School,
Infection,
Foundation,
Partnership,
Fever Dream,
Friendly,
Degenerative disease,
Aedes,
Health,
US,
Canine vector-borne disease,
Pharmaceutical industry,
Agriculture,
Vaccine,
Zika fever,
Paulo,
Wellcome To validate this next-generation Friendly Aedes aegypti in urban communities, season-long deployments against the disease-spreading Aedes aegypti mosquito were conducted across neighborhoods home to 45,000 residents in Indaiatuba.
Key Points:
- To validate this next-generation Friendly Aedes aegypti in urban communities, season-long deployments against the disease-spreading Aedes aegypti mosquito were conducted across neighborhoods home to 45,000 residents in Indaiatuba.
- The successes of this scale-up project are speeding the FriendlyAedes aegypti to wider impact, delivering greater affordability and operational accessibility for dengue-prone communities in Brazil and worldwide.
- Oxitec is now preparing to scale commercial operations in Brazil, rolling out FriendlyAedes aegypti to more communities, governments, and businesses over the coming mosquito season.
- Oxitec is the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock.
Retrieved on:
Thursday, August 18, 2022
Multimedia,
City,
Country,
University,
CEO,
Mental health,
Technology,
Metropolitan,
OXFORD,
Life,
Chikungunya,
Oxitec,
School,
Infection,
Foundation,
Partnership,
Fever Dream,
Friendly,
Degenerative disease,
Aedes,
Health,
US,
Canine vector-borne disease,
Pharmaceutical industry,
Agriculture,
Vaccine,
Zika fever,
Paulo,
Wellcome To validate this next-generation Friendly Aedes aegypti in urban communities, season-long deployments against the disease-spreading Aedes aegypti mosquito were conducted across neighborhoods home to 45,000 residents in Indaiatuba.
Key Points:
- To validate this next-generation Friendly Aedes aegypti in urban communities, season-long deployments against the disease-spreading Aedes aegypti mosquito were conducted across neighborhoods home to 45,000 residents in Indaiatuba.
- The successes of this scale-up project are speeding the FriendlyAedes aegypti to wider impact, delivering greater affordability and operational accessibility for dengue-prone communities in Brazil and worldwide.
- Oxitec is now preparing to scale commercial operations in Brazil, rolling out FriendlyAedes aegypti to more communities, governments, and businesses over the coming mosquito season.
- Oxitec is the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock.
Retrieved on:
Wednesday, April 13, 2022
CEO,
Aircraft,
Melinda Gates,
Aedes aegypti,
Friendly,
Population,
Bill & Melinda Gates Foundation,
Incidence,
Human,
Program,
World,
Goal,
Anopheles,
Malaria,
Progress,
Fever Dream,
Technology,
US,
Biting,
Environment,
Horn,
University,
Method,
Bill,
OXFORD,
Animal,
Insecticide,
Epidemic,
Male,
Disease,
World Health Organization,
Risk,
Vaccine,
Pharmaceutical industry,
Oxitec Oxitec's safe and targeted Friendly technology uses non-biting male mosquitoes to reduce pest populations and is proven against other disease-spreading mosquitoes.
Key Points:
- Oxitec's safe and targeted Friendly technology uses non-biting male mosquitoes to reduce pest populations and is proven against other disease-spreading mosquitoes.
- This multi-year international program will be supported by US$18 million of funding from the Bill & Melinda Gates Foundation.
- Oxitec's malaria program targets two malaria-spreading mosquitoes that pose major challenges to the international community's regional malaria eradication goals.
- Oxitec is the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock.
Retrieved on:
Wednesday, April 13, 2022
CEO,
Aircraft,
Melinda Gates,
Aedes aegypti,
Friendly,
Population,
Bill & Melinda Gates Foundation,
Incidence,
Human,
Program,
World,
Goal,
Anopheles,
Malaria,
Progress,
Fever Dream,
Technology,
US,
Biting,
Environment,
Horn,
University,
Method,
Bill,
OXFORD,
Animal,
Insecticide,
Epidemic,
Multimedia,
Male,
Disease,
World Health Organization,
Risk,
Vaccine,
Pharmaceutical industry,
Oxitec Oxitec's safe and targeted Friendly technology uses non-biting male mosquitoes to reduce pest populations and is proven against other disease-spreading mosquitoes.
Key Points:
- Oxitec's safe and targeted Friendly technology uses non-biting male mosquitoes to reduce pest populations and is proven against other disease-spreading mosquitoes.
- This multi-year international program will be supported by US$18 million of funding from the Bill & Melinda Gates Foundation.
- Malaria kills more than half a million people each year across the world and, according to the World Health Organization, nearly half of the world's population is at risk.
- Oxitec's malaria program targets two malaria-spreading mosquitoes that pose major challenges to the international community's regional malaria eradication goals.
The foundation\'s investment will enable us to expand our technology to improve the lives and livelihoods of communities around the world.
Key Points:
- The foundation\'s investment will enable us to expand our technology to improve the lives and livelihoods of communities around the world.
- The cattle tick is a devastating pest, causing high rates of cattle mortality, which in turn impacts the lives of farmers and food security globally.
- They bring an incredible depth of experience, innovation and passion that will help propel the development of a Friendly cattle tick.
- Cattle farmers are currently reliant on pesticides to manage these tick pests, and the cattle tick has become widely resistant to these chemicals making them even more difficult to control.\nThis cattle tick feasibility project joins the Oxitec pipeline of solutions being developed to deliver targeted biological control of pests.
Insects,
Zoonoses,
Hexapoda,
Oxitec,
Pest control,
Vale of White Horse,
Insect control,
Aedes aegypti,
Mosquito control,
Aedes,
Mosquito Oxitec\'s males are intended to reduce the number of potentially disease-transmitting female Aedes aegypti.\nThis project comes more than a decade after FKMCD first invited Oxitec to pilot its technology in the Keys.
Key Points:
- Oxitec\'s males are intended to reduce the number of potentially disease-transmitting female Aedes aegypti.\nThis project comes more than a decade after FKMCD first invited Oxitec to pilot its technology in the Keys.
- The project has received required regulatory approvals from federal and state regulators, including approvals by the U.S. Environmental Protection Agency (EPA) Florida Department of Agriculture and Consumer Services (FDACS).
- Extensive public consultation, education and engagement has been carried out and community support for the project remains high.\nAndrea Leal, Executive Director Florida Keys Mosquito Control District, said, "Our primary mission is to protect residents in the Florida Keys from all mosquitoes including the disease-transmitting Aedes aegypti.
- The Florida Keys Mosquito Control District remains committed to seeking out, environmentally-friendly and targeted tools to protect our residents and to preserve our wildlife.
CAMPINAS, Brazil, June 3, 2019 /PRNewswire/ --Oxitec Ltd., a UK-based biotechnology company specializing in developing novel, environmentally-sustainable pest management solutions, today announced the successful completion of the first field trial in Brazil of its 2nd Generation Friendly Aedes aegypti technology.
Key Points:
- CAMPINAS, Brazil, June 3, 2019 /PRNewswire/ --Oxitec Ltd., a UK-based biotechnology company specializing in developing novel, environmentally-sustainable pest management solutions, today announced the successful completion of the first field trial in Brazil of its 2nd Generation Friendly Aedes aegypti technology.
- The trial was designed to test a number of performance features of the 2nd Generation Oxitec's Friendly Aedes aegypti technology, including the performance outcomes generated by the use of two different mosquito release rate levels in dense urban environments.
- Wild Aedes aegyptinumbers were kept at low levels throughout the high season in all treated neighborhoods, whereas populations in areas untreated by Oxitec's Friendly Aedes aegypti rose as normal.
- The 2nd Generation Friendly Aedes aegypti carries a self-limiting gene that prevents female offspring from surviving, allowing for male-only production.
CAMPINAS, Brazil, June 3, 2019 /PRNewswire/ --Oxitec Ltd., a UK-based biotechnology company specializing in developing novel, environmentally-sustainable pest management solutions, today announced the successful completion of the first field trial in Brazil of its 2nd Generation Friendly Aedes aegypti technology.
Key Points:
- CAMPINAS, Brazil, June 3, 2019 /PRNewswire/ --Oxitec Ltd., a UK-based biotechnology company specializing in developing novel, environmentally-sustainable pest management solutions, today announced the successful completion of the first field trial in Brazil of its 2nd Generation Friendly Aedes aegypti technology.
- The trial was designed to test a number of performance features of the 2nd Generation Oxitec's Friendly Aedes aegypti technology, including the performance outcomes generated by the use of two different mosquito release rate levels in dense urban environments.
- Wild Aedes aegyptinumbers were kept at low levels throughout the high season in all treated neighborhoods, whereas populations in areas untreated by Oxitec's Friendly Aedes aegypti rose as normal.
- The 2nd Generation Friendly Aedes aegypti carries a self-limiting gene that prevents female offspring from surviving, allowing for male-only production.
This announcement comes after the successful conclusion of an initial three-year research and development collaboration that funded the early development of the self-limiting fall armyworm strain.
Key Points:
- This announcement comes after the successful conclusion of an initial three-year research and development collaboration that funded the early development of the self-limiting fall armyworm strain.
- The damage caused by fall armyworm requires new solutions to address the problem of resistance to traditional crop protection products.
- "Given the rising challenge of controlling this increasingly resilient and damaging agricultural pest, Oxitec's self-limiting fall armyworm could be a critical addition to current crop pest control options," said Kelly Matzen, Head of Research & Development at Oxitec.
- As the self-limiting fall armyworm progresses through these next stages of development, Oxitec will also pursue regulatory approval for field studies in Brazil to assess the field performance of the self-limiting fall armyworm in the environment.
This announcement comes after the successful conclusion of an initial three-year research and development collaboration that funded the early development of the self-limiting fall armyworm strain.
Key Points:
- This announcement comes after the successful conclusion of an initial three-year research and development collaboration that funded the early development of the self-limiting fall armyworm strain.
- The damage caused by fall armyworm requires new solutions to address the problem of resistance to traditional crop protection products.
- "Given the rising challenge of controlling this increasingly resilient and damaging agricultural pest, Oxitec's self-limiting fall armyworm could be a critical addition to current crop pest control options," said Kelly Matzen, Head of Research & Development at Oxitec.
- As the self-limiting fall armyworm progresses through these next stages of development, Oxitec will also pursue regulatory approval for field studies in Brazil to assess the field performance of the self-limiting fall armyworm in the environment.
